Trinity Biotech (TRIB) EBT Growth (3y) (2012 - 2024)
Trinity Biotech (TRIB) EBT Growth (3y) (2012 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.44 Bn | 193.84 Bn | 7.27 Bn | -2.34% |
| 2 | Stryker | 127.32 Bn | 123.85 Bn | 4.50 Bn | 20.27% |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 5.75% |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 35.51% |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.65 Bn | 1.35 Bn | 23.63% |
| 6 | Dexcom | 34.30 Bn | 32.36 Bn | 830.00 Mn | 25.85% |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn | 6.73% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 89.20% |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn | 17.92% |
| 10 | Trinity Biotech | 6.46 Mn | 1.32 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -86.68% |
| Sep 30, 2024 | -70.93% |
| Jun 30, 2024 | -277.54% |
| Mar 31, 2024 | -40.23% |
| Dec 31, 2023 | 27.22% |
| Sep 30, 2023 | -41.37% |
| Jun 30, 2023 | -133.90% |
| Mar 31, 2023 | -60.53% |
| Dec 31, 2022 | 30.09% |
| Sep 30, 2022 | -266.74% |
| Jun 30, 2022 | -367.99% |
| Mar 31, 2022 | -297.74% |
| Dec 31, 2021 | 54.13% |
| Sep 30, 2021 | 66.00% |
| Jun 30, 2021 | -29.42% |
| Mar 31, 2021 | 71.38% |
| Dec 31, 2020 | 29.99% |
| Sep 30, 2020 | 139.65% |
| Jun 30, 2020 | 26.14% |
| Mar 31, 2020 | 110.93% |